Trial intelligence / Profile preview

Isometric exercise and lidocaine for pain relief during propofol injection

IRCT20190109042309N1Phase 3Completed

Sponsor
Sabzevar University of Medical Sciences
Start
Feb 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of propofol and lidocaine in None (3 arms), sponsored by Sabzevar University of Medical Sciences. Primary endpoint: Intensity of pain. Started Feb 2019; status: completed.

02

Drugs

propofollidocaine

Beyond the preview

Go deeper on IRCT20190109042309N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190109042309N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call